Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Numab Therapeutics AG
Instituto do Cancer do Estado de São Paulo
Tempus AI